Metabolic reprograming of exhausted intratumoral CD8+ T‐cell underlies anti‐tumor activity of SUMOylation inhibitors in Large B Cell Lymphoma
Year: 2023
Type: conference-abstract
Abstract: The research was funded by: NIH/NCI R01CA266544 to AAM Keywords: Aggressive B-cell non-Hodgkin lymphoma, Metabolism, Targeting the Tumor Microenvironment No conflicts of interests pertinent to the abstract.
Source: Hematological Oncology
DOI: 10.1002/hon.3164_190
Institution: Cedars-Sinai Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4380085983
